Tempus AI operates at the highly complex intersection of molecular genomics and artificial intelligence, functioning essentially as a data aggregation and clinical deployment platform for precision medicine. The company’s core business is bifurcated into two primary operational segments: Diagnostics (Genomics) and Data & Applications. The Diagnostics segment utilizes next-generation sequencing (NGS) to provide hereditary risk assessment, therapy selection, and MRD monitoring7. The Data & Applications segment leverages a proprietary dataset exceeding 500 petabytes of clinico-genomic and imaging records to license insights, cohort analytics, and AI modeling to global biopharmaceutical firms

The structural industry trends strongly favor Tempus’s dual-sided business model. The global shift toward personalized oncology relies entirely on ...